Department of Physiotherapy, Middle East University, Amman, Jordan.
Applied Science Research Center, Applied Science Private University, Amman, Jordan.
PM R. 2024 Mar;16(3):268-277. doi: 10.1002/pmrj.13055. Epub 2023 Oct 5.
To investigate the effects of noninvasive brain stimulation (NIBS) on spasticity in people with multiple sclerosis (PwMS).
We searched PubMed, SCOPUS, MEDLINE, REHABDATA, PEDro, CINAHL, AMED, and Web of Science until December 2022.
Studies were selected if they included PwMS, used transcranial direct current stimulation (tDCS) or repetitive transcranial magnetic stimulation (rTMS) as a main intervention, and were randomized controlled trials (RCTs) including at least one outcome measure evaluating spasticity. Two researchers individually screened the selected studies. The study's quality was assessed using the Cochrane Collaborations tool. The researchers decided that the meta-analysis was not possible because the treatment interventions varied among the selected studies.
In total, 147 studies were reviewed. Of them, nine studies met the eligibility criteria and included 193 PwMS (mean age = 43.2 years), 54.4% of whom were female. Eight studies were considered "high" quality and one was considered "moderate" quality. Seven studies that used rTMS demonstrated a significant decrease in spasticity in PwMS after the intervention. The remaining studies that provided tDCS did not show meaningful effects.
The evidence for the influences of rTMS on spasticity in PwMS is promising. The evidence for the impact of tDCS on spasticity in PwMS was limited. Further RCTs with long-term follow-ups are encouraged.
研究非侵入性脑刺激(NIBS)对多发性硬化症(MS)患者痉挛的影响。
我们检索了 PubMed、SCOPUS、MEDLINE、REHABDATA、PEDro、CINAHL、AMED 和 Web of Science,截至 2022 年 12 月。
如果研究纳入了 MS 患者,将经颅直流电刺激(tDCS)或重复经颅磁刺激(rTMS)作为主要干预措施,并为随机对照试验(RCT),至少有一个评估痉挛的结局指标,则选择这些研究。两位研究人员单独筛选入选研究。使用 Cochrane 协作工具评估研究质量。研究人员决定进行荟萃分析是不可能的,因为入选研究中的治疗干预措施存在差异。
共审查了 147 项研究。其中,9 项研究符合入选标准,纳入了 193 名 MS 患者(平均年龄为 43.2 岁),其中 54.4%为女性。8 项研究被认为是“高质量”,1 项被认为是“中质量”。7 项使用 rTMS 的研究表明,干预后 MS 患者的痉挛显著减轻。其余提供 tDCS 的研究并未显示出有意义的效果。
rTMS 对 MS 患者痉挛的影响证据有一定的前景。tDCS 对 MS 患者痉挛影响的证据有限。鼓励进一步开展长期随访的 RCT 研究。